Back to Search Start Over

Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives

Authors :
Federica Vitali
Barbara Brina
Maria Angela Vandelli
Stefano Manfredini
Alessandro Dalpiaz
Elisa Durini
Eliana Leo
Angelo Scatturin
Barbara Pavan
Fabrizio Bortolotti
Flavio Forni
Publication Year :
2005

Abstract

We report a preliminary study concerning the encapsulation modalities in nanoparticles of the anti-ischemic drug N 6 -cyclopentyladenosine (CPA) and its pro-drug 5′-octanoyl-CPA (Oct-CPA). The release of these compounds and the related pro-drug stability effects in human whole blood have been tested. Moreover, the influence of the delivery systems on CPA interaction toward human adenosine A 1 receptor has been analysed. The nanospheres were prepared by nanoprecipitation or double emulsion solvent evaporation method using poly(lactic acid) and recovered by gel filtration or ultracentrifugation or dialysis. Free and encapsulated Oct-CPA was incubated in fresh blood and its stability was analysed with HPLC. Quite spherical nanoparticles with mean diameters ranging between 210±50 and 390±90 nm were obtained. No encapsulation occurred when CPA was used. Satisfactory results concerning drug content (0.1–1.1% w/w) and encapsulation efficiency (6–56%) were achieved when Oct-CPA was employed. The controlled release of the pro-drug was achieved, being released within a range of 1–4 h, or very slowly, depending on nanoparticle preparations. The hydrolysis rate of Oct-CPA in human whole blood appeared stabilized in human whole blood with modalities related to the release patterns. The presence of all nanoparticle preparations did not interfere with CPA interaction at its action site.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....58e17cf13ff5831d554ced7fce262d80